Motavizumab

Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III clinical trials.

单词	Motavizumab
释义	Motavizumab 英语百科 Motavizumab Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III clinical trials.
随便看	radices pseudoginseng radices pseudostellariae radices puerarire radices pulmonis radices pulsatillae radices ratanhiae radices rehmanniae radices rhapontici uniflori radices rhei radices rubiae radices salep radices salviae miltiorrhizae radices sanguisorbae radices saponariae radices sarsae radices sarsaparillae radices saussureae radices scammoniae radices scaussureae lappae radices scrophulariae radices scutellariae radices semiaquilegiae radices senegae radices serratulae radices seseli